LE Fox, MC Locke, DJ Lenschow - Frontiers in immunology, 2020 - frontiersin.org
Type I interferons (IFNs) are critical effector cytokines of the immune system and were originally known for their important role in protecting against viral infections; however, they …
L Evgin, AL Huff, P Wongthida, J Thompson… - Nature …, 2020 - nature.com
The application of adoptive T cell therapies, including those using chimeric antigen receptor (CAR)-modified T cells, to solid tumors requires combinatorial strategies to overcome …
RM Van der Sluis, JM Zerbato, JW Rhodes… - PLoS …, 2020 - journals.plos.org
HIV latency is the major barrier to a cure for people living with HIV (PLWH) on antiretroviral therapy (ART) because the virus persists in long-lived non-proliferating and proliferating …
NA de Weerd, JP Vivian, SS Lim… - Journal of Leucocyte …, 2020 - academic.oup.com
The type I IFNs activate an array of signaling pathways, which are initiated after IFNs bind their cognate receptors, IFNα/β receptor (IFNAR) 1 and IFNAR2. These signals contribute to …